OLMA · NASDAQ · Biotechnology

Olema Pharmaceuticals (OLMA)

Develops oral therapies for breast cancer and other endocrine-driven tumors.

$9.64
After hours−0.04 (−0.41%)
At close$9.68(+0.52%)